Clearside Biomedical Inc (CLSD) Stock offers help to cash-strapped investors

Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]

Top-line Growth is Likely to Be Driven by Clearside Biomedical Inc (CLSD) Stock

Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]

Analyzing Clearside Biomedical Inc’s (CLSD) Stock earnings per share and revenue

Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]

The Technical Story of Clearside Biomedical Inc (CLSD) Stock

Wedbush lowered the price target for the Clearside Biomedical Inc (NASDAQ:CLSD) stock to “an Outperform”. The rating was released on December 15, 2021, according to finviz. The research report from ROTH Capital has initiated the stock to Buy, with a price target set at $8. Historical Earnings Surprises and Revenue Forecasts Profit is the most […]